Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Singhal

Showing results (741-750 of 791) with videos related to

Pageof 80
Sort By:
Bone Marrow Transplantation|March 21, 2000
Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 yearsS Kulkarni, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|March 14, 2000
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan aloneK R Desikan, G Tricot, M Dhodapkar, et al.
Journal of Clinical Medicine|August 10, 2024
Phenotypic Plasticity and Cancer: A System Biology PerspectiveAyalur Raghu Subbalakshmi, Sravani Ramisetty, Atish Mohanty, et al.
Bone Marrow Transplantation|October 19, 2001
CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocritJ Mehta, Y Oyama, J Winter, et al.
Blood|December 24, 1998
Age is not a prognostic variable with autotransplants for multiple myelomaD S Siegel, K R Desikan, J Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Peripheral blood mononuclear cell transcriptomic trajectories reveal dynamic regulation of inflammatory actors in deliriumSara C LaHue, Naoki Takegami, Rubinee Simmasalam, et al.
Cancers|July 20, 2021
Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary CarcinogenesisSharda P Singh, Jihyun Lee, Chhanda Bose, et al.
Bone Marrow Transplantation|March 16, 2002
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemiaS Singhal, R Powles, P J Henslee-Downey, et al.
Current Opinion in Biotechnology|April 5, 2015
Chaotropicity: a key factor in product tolerance of biofuel-producing microorganismsJonathan A Cray, Andrew Stevenson, Philip Ball, et al.
Bone Marrow Transplantation|October 7, 2008
Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?V Singh, J Krishnamurthy, S Duffey, et al.
Pageof 80

Showing results (741-750 of 791) with videos related to

Sort By:
Pageof 80
Bone Marrow Transplantation|March 21, 2000
Melphalan/TBI is not more carcinogeneic than cyclophosphamide/TBI for transplant conditioning: follow-up of 725 patients from a single centre over a period of 26 yearsS Kulkarni, R Powles, J Treleaven, et al.
Bone Marrow Transplantation|March 14, 2000
Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan aloneK R Desikan, G Tricot, M Dhodapkar, et al.
Journal of Clinical Medicine|August 10, 2024
Phenotypic Plasticity and Cancer: A System Biology PerspectiveAyalur Raghu Subbalakshmi, Sravani Ramisetty, Atish Mohanty, et al.
Bone Marrow Transplantation|October 19, 2001
CD34(+) cell collection efficiency does not correlate with the pre-leukapheresis hematocritJ Mehta, Y Oyama, J Winter, et al.
Blood|December 24, 1998
Age is not a prognostic variable with autotransplants for multiple myelomaD S Siegel, K R Desikan, J Mehta, et al.
Medrxiv : the Preprint Server for Health Sciences|March 4, 2025
Peripheral blood mononuclear cell transcriptomic trajectories reveal dynamic regulation of inflammatory actors in deliriumSara C LaHue, Naoki Takegami, Rubinee Simmasalam, et al.
Cancers|July 20, 2021
Haploinsufficiency Interactions between RALBP1 and p53 in ERBB2 and PyVT Models of Mouse Mammary CarcinogenesisSharda P Singh, Jihyun Lee, Chhanda Bose, et al.
Bone Marrow Transplantation|March 16, 2002
Allogeneic transplantation from HLA-matched sibling or partially HLA-mismatched related donors for primary refractory acute leukemiaS Singhal, R Powles, P J Henslee-Downey, et al.
Current Opinion in Biotechnology|April 5, 2015
Chaotropicity: a key factor in product tolerance of biofuel-producing microorganismsJonathan A Cray, Andrew Stevenson, Philip Ball, et al.
Bone Marrow Transplantation|October 7, 2008
Actual or ideal body weight to calculate CD34+ cell dose in patients undergoing autologous hematopoietic SCT for myeloma?V Singh, J Krishnamurthy, S Duffey, et al.
Pageof 80